Articles related to Pathology

Unveiling the Secret to Superior Cognitive Health in the Oldest-Old In a breakthrough research, an understanding of the resistance of certain 90+ individuals to neurodegenerative pathologies leading to superior cognitive abilities emerges, presenting avenues for preserving cognitive health in advanced ages. Key Points: “There are some individuals who can maintain high levels of cognitive function well into advanced ages. Further research into the factors that enable these individuals to maintain their cognitive function could provide insights into how to preserve cognitive health despite advanced age.” María M. Corrada, ScD, co-principal investigator of the study

HER2-Directed ADCs in Gastric Cancer Several antibody-drug conjugates (ADCs) have recently received approval for use in treating a range of solid cancers. This poses difficulties when handling a variety of adverse treatment-related events, some of which can take practitioners into uncharted area. After viewing this CME activity, medical oncologists, pulmonologists, urologists, pathologists, oncology NPs, PAs, oncology nurses, oncology pharmacists, and other HCPs caring for patients with solid tumors should be able to describe the elements of an antibody-drug conjugate (ADC) that may cause adverse events (AEs), identify AEs that result in treatment interruption or discontinuation, and suggest a strategy for managing the key AEs.

Medical oncologists, pulmonologists, pathologists, oncology nurses, pharmacists, and other oncology HCPs who treat patients with lung cancer should be better able to describe ideal evidence-based treatment selection and sequencing recommendations for the use of immuno-oncologic therapy in patients with early-stage NSCLC and evaluate clinical trial data of emerging immunotherapy-based agents in the treatment after completing this three-chapter, 0.50-credit CME activity.

Naegleria fowleri — a “free-living amoeba” and cousin of E. histolytica —enters humans not through the mouth but through the nose, and in a few, penetrates the nasal mucosa to invade the brain.

The Lumipulse G β-Amyloid Ratio (1-42/1-40) test could potentially eliminate the need for positron emission tomography (PET) scans to assess amyloid plaques in patients’ brains, Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, said in a statement.

Burkholderia pseudomallei bacteria showed up in four patients in Georgia, Kansas, Minnesota, and Texas in 2021, despite the bacterium typically associated with travel to tropical and subtropical areas like Thailand and Malaysia. The case was cracked when researchers found an essential oil spray that contained B. pseudomallei in the home of a 4-year-old boy who died from complications of the melioidosis outbreak.